Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Liabilities and Shareholders Equity (2016 - 2025)

MedWellAI (MWAI) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $460888.0 as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 83.63% to $460888.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.7 million, a 77.03% decrease, with the full-year FY2025 number at $805500.0, down 79.57% from a year prior.
  • Liabilities and Shareholders Equity was $460888.0 for Q4 2025 at MedWellAI, down from $549872.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $16.3 million in Q2 2022 to a low of $460888.0 in Q4 2025.
  • A 5-year average of $8.3 million and a median of $5.8 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 2517.66% in 2021, then crashed 84.0% in 2025.
  • MedWellAI's Liabilities and Shareholders Equity stood at $16.2 million in 2021, then decreased by 3.54% to $15.6 million in 2022, then crashed by 65.07% to $5.4 million in 2023, then plummeted by 48.29% to $2.8 million in 2024, then plummeted by 83.63% to $460888.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Liabilities and Shareholders Equity are $460888.0 (Q4 2025), $549872.0 (Q3 2025), and $805500.0 (Q2 2025).